Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116041207A reveals a novel chiral spiroindane ligand enabling high-selectivity C-H activation. Discover cost-effective synthesis and supply chain advantages.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.
Patent CN105884728B details air-oxidized NHC catalysis for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN116554054B reveals efficient styrene-based synthesis for ketoprofen and loxoprofen intermediates offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Advanced ruthenium catalyst technology for cyclic carbonate hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN108164555B reveals a high-efficiency rare earth catalyst for boronic ester synthesis, offering mild conditions and significant cost reduction in fine chemical manufacturing.
Patent CN115650837B reveals a green blue-light catalyzed method for ketone synthesis offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108383863A reveals efficient lithium catalyst for borate esters. Reduces cost and time for pharmaceutical intermediate manufacturing with high purity.
Patent CN103420842B reveals a novel route for 2,3,4-trifluoronitrobenzene offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104945254A reveals a novel Fe-Cu catalyzed synthesis for condensed ring esters, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113444076A details a green three-component synthesis for fluorinated quinoxalinones, offering recyclable catalysis and reduced metal residues for pharmaceutical manufacturing.
Patent CN113444076A reveals a recyclable chitosan-copper catalyst for synthesizing fluorinated quinoxalinones, offering sustainable cost reduction and high purity for pharma manufacturing.
Patent CN1926083B details a novel ruthenium-catalyzed asymmetric hydrogenation method for producing high-purity optically active alcohols with superior stereoselectivity and yield.
Patent CN114394903A reveals a high-yield synthesis of perfluoroalkyl anilines using cheap 2-bromoheptafluoropropane and ammonium chloride, offering significant cost reduction.
Patent CN111500652B reveals enzymatic route for florfenicol. Reduces waste and cost. Ideal for veterinary drugs supply chain optimization and high-purity manufacturing.
Novel Ytterbium catalyzed route for Upadacitinib intermediate ensures high purity and cost efficiency for global pharmaceutical supply chains and reliable sourcing.
Novel patent CN103145574B details efficient diclofenac sodium production. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Novel cobalt complexes enable selective internal alkyne hydroboration. Reduces reliance on precious metals for high-purity organoboron intermediate manufacturing.
Patent CN112321424B reveals a novel inorganic base catalyzed route for 2S-(+)-flurbiprofen axetil, offering superior optical purity and yield for reliable pharmaceutical intermediate supply chains.
Advanced Raney Nickel catalyzed synthesis of butylphthalide eliminates high-energy rectification. Delivers >99% purity for reliable API intermediate supply chains.